CompanyDrug

Innovent Biologics Doses First Subject in IBI324 Phase I Study for DME

CompanyDrug

Immvira’s Oncolytic Virus MVR-C5252 Receives FDA Orphan Drug Designation for Glioma

CompanyLegal / IP

Transcenta Appoints Dr. Caroline Germa as Global Drug Development Chief

HospitalPolicy / Regulatory

NHC Issues Notification on Medication Safety Management and Rational Drug Use

CompanyDeals

Ningbo Health Gene Raises Hundreds of Millions in Series C Financing

CompanyMedical Device

Intuitive Surgical-Fosun JV Breaks Ground on Shanghai Medical Robot Base

Company

Bayer AG’s Q2 2022 Results Show Global Sales Growth Amid China VBP Pressures

CompanyDeals

Intellective Biologics Raises Over RMB500m in Series C Financing Round

CompanyDeals

MicuRx Pharmaceuticals Completes RMB1.06B IPO for Antibacterial Drug Development

CompanyDeals

invoX Pharma Extends Tender Offer for F-star Therapeutics to September 19

CompanyDrug

Merck Launches Prevymis, a Non-Nucleoside CMV Inhibitor, in China

Company

BeiGene’s Q2 2022 Revenues Surge 120%, Brukinsa Sales Triple